US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Portfolio Building Block World Pharma and Biotech Index ETF

28.37

-0.1233-0.43%

Post-market: 28.400.0278+0.10%19:30 EDT

Volume:114.43K

Turnover:3.25M

Market Cap:1.03B

PE:- -

High:28.43

Open:28.43

Low:28.28

Close:28.50

52wk High:29.90

52wk Low:24.24

Shares:36.31M

Float Shares:36.31M

Volume Ratio:1.41

T/O Rate:0.32%

Dividend:0.02

Dividend Rate:0.08%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Leadership Departure and Flawed Compensation Clauses Cast Doubt on Ruifeng's Acquisition Deal

Indonesia Suspends 26 Corporate Permits over Forest Fires

Structure weakness ‘disconnected’ from underlying data, says Jefferies

Structure Therapeutics reports ACCG-2671, aleniglipron trial results

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/PBPH"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"PBPH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBPH\",,,,,undefined,":{"symbol":"PBPH","market":"US","secType":"STK","nameCN":"Portfolio Building Block World Pharma and Biotech Index ETF","latestPrice":28.3722,"timestamp":1789761600000,"preClose":28.4955,"halted":0,"volume":114433,"hourTrading":{"tag":"盘后","latestPrice":28.4,"preClose":28.3722,"latestTime":"19:30 EDT","volume":7,"amount":198.6054,"timestamp":1789774205434,"change":0.0278,"changeRate":0.00098,"amplitude":0},"delay":0,"changeRate":-0.004326998999842095,"floatShares":36310000,"shares":36310000,"eps":0,"marketStatus":"Market Closed","change":-0.1233,"latestTime":"09-18 16:00:00 EDT","open":28.43,"high":28.43,"low":28.2823,"amount":3245742.13777,"amplitude":0.005183,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789977600000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":28.4955,"nav":28.433261,"aum":1032411706.91,"dividendRate":0.000807,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":28.4,"preClose":28.3722,"latestTime":"19:30 EDT","volume":7,"amount":198.6054,"timestamp":1789774205434,"change":0.0278,"changeRate":0.00098,"amplitude":0},"volumeRatio":1.4131019980509474},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBPH\",,,,,undefined,":{"symbol":"PBPH","floatShares":36310000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.4131019980509474,"shares":36310000,"dividePrice":0.022885,"high":28.43,"amplitude":0.005183,"preClose":28.4955,"low":28.2823,"week52Low":24.241,"pbRate":"--","week52High":29.9,"institutionHeld":0,"latestPrice":28.3722,"eps":0,"divideRate":0.000807,"volume":114433,"delay":0,"ttmEps":0,"open":28.43,"prevYearClose":25.2428,"prevWeekClose":27.8041,"prevMonthClose":28.6563,"prevQuarterClose":27.177,"fiveDayClose":27.8041,"twentyDayClose":29.2122,"sixtyDayClose":26.0991},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PBPH\",params:#limit:5,,,undefined,":[{"date":"2025-12-24","symbol":"PBPH","amount":0.022885,"announcedDate":"2025-12-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-24","defaultRemindTime":1766586600000,"name":"Portfolio Building Block World Pharma and Biotech Index ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-24","currency":"USD","dateTimestamp":1766552400000,"payDate":"2025-12-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PBPH\",market:\"US\",,,undefined,":[{"executeDate":"2025-12-24","recordDate":"2025-12-24","paymentDate":"2025-12-26","value":0.022885,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PBPH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PBPH\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1161329651","title":"Leadership Departure and Flawed Compensation Clauses Cast Doubt on Ruifeng's Acquisition Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=1161329651","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161329651?lang=en_us&edition=fundamental","pubTime":"2026-09-20 15:30","pubTimestamp":1789889447,"startTime":"0","endTime":"0","summary":"Shandong Ruifeng Chemical Co.,Ltd. (300243.SZ) has unveiled further details of its acquisition plan, which has been in the works for over a month. The company recently announced its intention to...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0229","XLFI","ACTV","BK0177","IEFN","PBPH","IBBQ","BK0086","CANC","PEVC","AAUM","BK0028","UYG","BK4588","DFMC","FFSM","RSPH","PSP","MNA","GTPE","300243","BK4585","TMED","PRVT","RFG","IYH","TBXU","MMID","VXF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667605626","title":"Indonesia Suspends 26 Corporate Permits over Forest Fires","url":"https://stock-news.laohu8.com/highlight/detail?id=2667605626","media":"Tempo","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667605626?lang=en_us&edition=fundamental","pubTime":"2026-09-16 15:45","pubTimestamp":1789544727,"startTime":"0","endTime":"0","summary":"TEMPO.CO, Jakarta -Forestry Minister Raja Juli Antoni stated that his ministry has suspended the operational permits of 26 companies in connection with land and forest fires.Raja Juli explained that the permit suspensions is part of enforcement measures spearheaded by the Directorate General of Forestry Law Enforcement . This involves administrative sanctions that may be paired with mandatory environmental restoration and can escalate to criminal prosecution if evidence of unlawful acts emerges.\"In our Gakkum unit at the Ministry of Forestry, we have frozen the business permits of 26 corporate entities,\" said Raja Juli after a working meeting with Commission IV of the Indonesian House of Representatives  in Jakarta on Wednesday.","market":"hk","thumbnail":"https://statik.tempo.co/data/2026/09/05/id_1488451/1488451_720.jpg","type":0,"news_type":0,"thumbnails":["https://statik.tempo.co/data/2026/09/05/id_1488451/1488451_720.jpg"],"rights":{"source":"tempo_highlight","url":"https://en.tempo.co/read/2119695/indonesia-suspends-26-corporate-permits-over-forest-fires","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://en.tempo.co/read/2119695/indonesia-suspends-26-corporate-permits-over-forest-fires","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tempo_highlight","symbols":["PBPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666377632","title":"Structure weakness ‘disconnected’ from underlying data, says Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2666377632","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666377632?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:00","pubTimestamp":1788897615,"startTime":"0","endTime":"0","summary":"After Structure Therapeutics (GPCR) reported clinical trial results from its two lead product candidates, ACCG-2671 and aleniglipron, Jefferies see...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/structure-weakness-disconnected-from-underlying-data-says-jefferies-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/structure-weakness-disconnected-from-underlying-data-says-jefferies-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FBT","XPH","SURI","FHLC","IDNA","BME","TBXU","HYLG","IBRN","IBBJ","BBH","IBBQ","PTH","CANC","IBB","WDNA","IEIH","SBIO","PSCH","PINK","HRTS","FXH","MDTX","BBP","APXH","BIB","CURE","JHMH","RSPH","MEDI","SYNB","MEDX","GDOC","PJP","MRNY","LFSC","AZNH","GPCR","MNTL","NVIB","JDOC","PBPH","PSIL","GNMX","PBE","LLYX","GSKH","GNOM","CNCR","FTXH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665637847","title":"Structure Therapeutics reports ACCG-2671, aleniglipron trial results","url":"https://stock-news.laohu8.com/highlight/detail?id=2665637847","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665637847?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:36","pubTimestamp":1788871007,"startTime":"0","endTime":"0","summary":"Structure Therapeutics (GPCR) reported clinical trial results from its two lead product candidates: ACCG-2671, an oral, non-peptide, small molecule...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/structure-therapeutics-reports-accg-2671-aleniglipron-trial-results-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/structure-therapeutics-reports-accg-2671-aleniglipron-trial-results-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BME","IBB","LENZ","LFSC","JDOC","PBE","SYNB","LLYX","FHLC","PTH","RSPH","CANC","NVIB","PJP","CURE","HRTS","GNMX","PINK","IDNA","BIB","GNOM","IBBJ","AZNH","TBXU","PBPH","MNTL","PSIL","WDNA","CNCR","FXH","IBBQ","FBT","FTXH","BBP","MDTX","SURI","MRNY","XPH","APXH","PSCH","GDOC","MEDX","BBH","GSKH","MEDI","IBRN","SBIO","HYLG","JHMH","GPCR"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":3,"pageCount":1,"totalSize":9,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/PBPH\",params:#limit:6,delay:false,,,undefined,":[]}}